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A Spontaneously Arising Mutation in the DLAARN
Motif of Murine ZAP-70 Abrogates Kinase Activity
and Arrests Thymocyte Development
DavidL. Wiest,*‖Jennifer M. Ashe,*T. Kevin Howcroft,* al., 1994; Hashimoto et al., 1996), particularly the Syk-
family PTK ZAP-70 (Chan et al., 1991, 1992). Indeed,Hon-Man Lee,² Debbie M. Kemper,² Izumi Negishi,³
Dinah S. Singer,* Alfred Singer,* and Ryo Abe²§ thymocyte development is arrested in genetically engi-
neered animals that do not express ZAP-70 protein*Experimental Immunology Branch
National Cancer Institute (Negishi et al., 1995). While it is clear that ZAP-70 PTK
molecules are necessary for thymocyte development,National Institutes of Health
Bethesda, Maryland 20892 the precise role of ZAP-70 in this process remains un-
clear. One role for ZAP-70 in thymocyte development²Immune Cell Biology Department
Naval Medical Research Institute might be to propagate TCR signals by phosphorylating
cytosolic proteins, such as SLP-76, that are part of theBethesda, Maryland 20889
³Nippon Roche Research Center TCR signaling cascade (Wardenburg et al., 1996). Alter-
natively, by phosphorylation of its tyrosine residues,Kamukura-shi, Kanagawa 247
Japan ZAP-70 might serve as a scaffold to which signaling
molecules are recruited and assembled into signaling§Division of Immunobiology
Research Institute for Biological Science complexes. In fact, it has beenproposed that the primary
function of ZAP-70 kinase activity is to create this scaf-Science University of Tokyo
Tokyo, Chiba 278 fold by autophosphorylation (Neumeister et al., 1995).
In this report, we describe a novel, spontaneouslyJapan
arising mutation of arginine to cysteine at position 464
(R464C) in a highly conserved motif within the kinase
domain of ZAP-70 (DLAARN) (Hanks and Quinn, 1991)Summary
that abrogates ZAP-70 kinase activity, blocks signaling
though the TCR complex, and arrests thymocyte devel-Development of immature CD41CD81 thymocytes into
opment, but does so without preventing phosphoryla-functionally mature CD41 and CD81 T cells is driven
tion of ZAP-70.by selection events that require signals transduced
through the T cell antigen receptor (TCR). Transduc-
tion of TCR signals in the thymus involves tyrosine Results
phosphorylation of the protein tyrosine kinase ZAP-70
by p56lck and results in induction of ZAP-70 enzymatic While inbreeding mice that were heterozygous for tar-
activity. We have identified a novel, spontaneously geted disruption of the CD28 gene, we found a number
arising point mutation within a highly conserved motif of mice that were devoid of peripheral T lymphocytes,
(DLAARN) in the kinase domain of murine ZAP-70 that a phenotype we named ªSTº (for ªstrangeº) (Shahinian,
uncouples tyrosine phosphorylation of ZAP-70 from et al., 1993). The ST phenotype was heritable and segre-
induction of ZAP-70 kinase activity. Mice homozygous gated as an autosomal recessive. Indeed, all F1 progeny
for this mutation are devoid of mature T cells because from ST 3 ST matings were phenotypically ST, whereas
thymocyte development is arrested at the CD41CD81 all F1 progeny from mating STmice with normal C57BL/6
stage of differentiation. The developmental arrest is (B6) animals were phenotypically normal. In addition,
due to the inability of CD41CD81 thymocytes to propa- intercrossing the normal F1 progeny of ST 3 B6 matings
gate TCR signals in the absence of ZAP-70 kinase resulted in expression of the ST phenotype in 29 of 127
activity despite tyrosinephosphorylation ofTCR-asso- (approximately one fourth) of the resultant F2 progeny.
ciated ZAP-70 molecules. Although originally identified in CD281/2 heterozygous
mice, the ST phenotype segregated independently of
Introduction CD28 expression. All ST mice described in this report
were homozygous CD281/1 and did not contain the
The repertoire of T cell antigen receptor (TCR) specifici- gene-targeting vector in their genomic DNA. We con-
ties expressed by mature CD41 and CD81 T cells is clude that the ST phenotype resulted from a spontane-
selected from among the wider array of immature T ous mutation that occurred either in vivo in the CD281/2
cell precursors in the thymus. This selection process heterozygous animal colony or in vitro in the embryonic
is exerted on thymocytes at the CD41CD81 stage of stem cell line from which theCD281/2 mice were derived.
differentiation in that CD41CD81 thymocytesexpressing The peripheral lymphoid organs of ST mice lacked
TCRs reactive with self-antigens are deleted, whereas both CD41 and CD81 T cells but contained B2201 B
those expressing TCRs with potential reactivity against lymphocytes (Figure 1A), indicating that the effects of
foreign antigens are signaled to mature into CD41 or the ST mutation were limited to the T cell lineage.Thymic
CD81 T cells (Robey and Fowlkes, 1994). These selec- cellularity was significantly reduced in ST mice, and
tion processes are dependent on TCR signals mediated ST thymocytes failed to mature beyond the CD41CD81
by protein tyrosine kinase (PTK) molecules (Littman et stage of development (Figure 1A). The developmental
arrest of ST thymocytes was not the result of defects
in either TCRa or TCRb expression, since the ST pheno-‖Present address: Fox Chase Cancer Center, Division of Basic Sci-
ences, Philadelphia, Pennsylvania 19111. type was not affected by introduction of productively
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Figure 1. ST Mice Lack Peripheral T Cells Because of an Arrest in
Thymocyte Development
(A and B) Spleen, lymph node, and thymus cells from WT B6 and
ST mice (A) and from WT and ST mice expressing the DO.11.10
TCRab transgenes (B) were analyzed by immunofluorescence and
multicolor flow cytometry. Cells were stained for CD4 versus CD8
expression to identify CD42CD82, CD41CD81, CD41CD82, or
CD42CD81 T cell subsets (top) and for Thy1.2 versus B220 expres-
sion to identify Thy11 T cells and B2201 B cells (bottom). Spleen
and lymph nodes of ST mice were essentially devoid of T lympho-
cytes but did contain normal numbers of B cells. The thymi of ST
mice contained only immature CD42CD82 and CD41CD81 thymo-
cytes and were devoid of mature CD41CD82 and CD42CD81 T cells.
(C and D) TCRb and CD5 surface expression were assessed
on thymocytes from WT and ST mice (C) and on thymocytes
from WT and ST mice expressing the D0.11.10 TCRab transgenes
(TCR-Tg) (D).
(E) TCR subunits of ST thymocytes display normal electrophoretic mobility. Detergent extracts of surface biotin±labeled TCR-transgenic WT
and ST thymocytes were immunoprecipitated with anti-TCRb MAb (H57±597), and the resultant immune complexes were resolved on two-
dimensional electrophoresis gels based on charge in the first dimension (nonequilibrium pH-gradient electrophoresis) and size in the second
dimension (SDS-PAGE). The migration position of each TCR subunit is indicated.
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Figure 2. Defective TCR Signaling in ST Thy-
mocytes
(A) ST thymocytes are unable to mobilize in-
tracellular calcium in response to co-cross-
linking of surface TCR and CD4. Intracellular
calcium mobilization in response to TCR sig-
naling was assessed in purified CD41CD81
thymocytes from WT and ST nontransgenic
thymocytes (top) and in WT and ST transgenic
mice expressing the DO.11.10 TCRab
transgenes (TCR-Tg) (bottom). Crosslinking
of surface receptors was accomplished by
addition of streptavidin to thymocytes that
had been stained with biotin-labeled anti-
TCRb MAbeither alone or in combination with
biotin-labeled anti-CD4 or anti-CD8 MAbs.
(B) Co-crosslinking of TCR 1 CD4 fails to in-
duce tyrosine phosphorylation of PLCg in ST
thymocytes. Tyrosine phosphorylation of
PLCg was measured in CD41CD81 thymo-
cytes from normal littermate (LM) or ST mice
after 5 min of TCR 1 CD4 co-crosslinking.
PLCg was isolated by immunoprecipitation
with specific antibody (anti-PLCg), resolved
by SDS-PAGE, and then blotted with anti-
phosphotyrosine MAb (4G10). Bound antibody
was visualized using horseradish peroxidase±
conjugated protein A and chemilumines-
cence. The same membranes were then
washed and reprobed with anti-PLCg anti-
body, and bound antibody was visualized by
125I-protein A and autoradiography.
rearranged TCRa and TCRb (D011.10) transgenes (Fig- in CD41CD81 thymocytes from WT normal mice, but
failed to mobilize intracellular calcium in ST thymocytes,ure 1B) (Murphy et al., 1990). Surface TCR levels were
reduced on ST thymocytes (Figure 1C), including ST even ST thymocytes expressing TCRab transgenes (Fig-
ure 2A). The failure of ST thymocytes tomobilize intracel-thymocytes expressing TCRab transgenes (Figure 1D),
but reduced TCR expression was most likely a conse- lular calcium was specific to T lineage cells, since B
lymphocytes from ST mice mobilized calcium effectivelyquence rather than a cause of the developmental arrest
in ST mice, since TCR expression was only marginally in response to crosslinking of their antigen receptors
(data not shown).lower than that on the TCRlo subset of normal wild-type
(WT) CD41CD81 thymocytes. Furthermore, all subunits To identify the defective signaling step in ST thymo-
cytes, we examined events in the TCR signaling cascade(a, b, g, d, e, and z) of the complete TCR complex were
present on ST thymocytes, and their charge and size that were proximal tocalcium mobilization. Since activa-
tion of phospholipase Cg (PLCg) is necessary for hydro-appeared normal as revealed by migration in two-dimen-
sional nonequilibrium pH-gradient electrophoresis (Fig- lysis of phosphatidylinositol and for intracellular calcium
mobilization (June et al., 1990; Secrist et al., 1991; Weissure 1E).
In contrast to TCR expression, surface expression et al., 1991; Weiss and Littman, 1994), we first asked
whether stimulation of ST thymocytes induced phos-of the activation marker CD5 (Punt et al., 1994) was
significantly reduced on ST thymocytes (including ST phorylation of PLCg (Figure 2B). Even though ST thymo-
cytes expressed normal levels of PLCg protein, PLCgthymocytes expressing TCRab transgenes) to levels far
below those on normal WT thymocytes (Figures 1C and phosphorylation was not induced in ST thymocytes by
TCR 1 CD4 co-crosslinking (Figure 2B), suggesting that1D), suggesting that TCR signal transduction might be
defective in ST mice. To assess directly the signaling the signaling defect in ST thymocytes was proximal to
PLCg phosphorylation. Consequently, we next exam-competence of ST thymocytes, we measured the mo-
bilization of intracellular calcium in freshly isolated ined tyrosine phosphorylation of the PTK ZAP-70, which
is a precondition for TCR-induced calcium mobilizationCD41CD81 thymocytes from bothWT and ST mice. Anti-
body-induced TCR crosslinking alone or in combination and thus is also likely to be required for TCR-induced
PLCg phosphorylation (Kolanus et al., 1993; Chan et al.,with CD8 failed to mobilize significant amounts of intra-
cellular calcium from any of the mice tested (Figure 2A), 1994a; Bolen, 1995; Gelfand et al., 1995; Wange et al.,
1995a; Kong et al., 1996). Interestingly, TCR 1 CD4 co-as has previously been reported (Nakayama et al., 1990;
Wiest et al., 1996).However, antibody induced co-cross- crosslinking induced tyrosine phosphorylation of ZAP-
70, as detected by anti-phosphotyrosine immunoblot-linking of surface TCR and CD4 molecules (TCR 1 CD4)
was highly effective in mobilizing intracellular calcium ting, in CD41CD81 thymocytes from both normal B6 and
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Figure 3. Identification of a Mutation in ZAP-70
as the Cause of the ST Phenotype
(A) Assessment of tyrosine phosphorylation
and tyrosine kinase activity in anti-ZAP-70 im-
munoprecipitates from stimulated CD41CD81
thymocytes. CD41CD81 thymocytes from
normal B6 and ST mice were stimulated for
5 min either by TCR 1 CD4 co-crosslinking
or with pervanadate (VO4), after which anti-
ZAP-70 immunoprecipitates were divided
into equal halves and evaluated in parallel
for tyrosine phosphorylation (left) and in vitro
tyrosine kinase activity (right). Radiolabeled
bands in the kinase assay result from the in-
corporation of 32P, revealing the presence of
an activated PTK in the anti-ZAP-70 immuno-
precipitation. (It might be appreciated that
pervanadate oxidizes thiol groups and so
can disrupt cysteine-dependent interactions,
such as those between CD4 and Lck. Conse-
quently, nonZAP-70±induced background
bands that are present in the immune com-
plex kinase assayof anti-ZAP-70 immunopre-
cipitates from unstimulated cells may be ab-
sent in those of pervanadate-stimulated
cells.) RF, running front.
(B) The defects in ZAP-702/2 and ST mice are
not complementary. Mice homozygous for
ablation of their ZAP-70 genes (ZAP2/2) were
mated with ST mice. Thymi from various mice,
including offspring of ST 3 ZAP2/2 matings,
were assessed for CD4 versus CD8 expres-
sion. Mature CD41 and CD81 T cells were
lacking in thymi from all (5 of 5) ST 3 ZAP2/2
offspring tested.
(C) ZAP-70 from ST thymocytes is expressed
at approximately one fourth of normal levels
and displays normal electrophoretic migra-
tion. Whole-cell lysates of CD41CD81 thymo-
cytes from normal littermate (LM) and ST
mice were electrophoresed and immunoblot-
ted with anti-ZAP-70 antibody and anti-Lck
antibody as a loading control. Bound anti-
bodies were visualized by horseradish perox-
idase±conjugated protein A and chemilumi-
nescence.
ST mice (Figure 3A, lanes 2 and 5). Thus, the signaling kinase assay and anti-phosphotyrosine immunoblot (Fig-
ure 3A). In addition to inducing ZAP-70 phosphorylationdefect in ST mice is distal to ZAP-70 phosphorylation
but proximal to PLCg phosphorylation. (Figure 3A, lanes 2 and 5), TCR 1 CD4 co-crosslinking
appeared to induce in vitro PTK activity in anti-ZAP-70Although ZAP-70 can be phosphorylated at different
tyrosine residues, only the phosphorylation of Y493 in its immunoprecipitates from both ST and WT thymocytes
(Figure 3A, lanes 8 and 11). However, since the immuno-kinase domain is known to be relevant for its activation
(Watts et al., 1994; Chan et al., 1995; Wange et al., 1995b; precipitates also contained detectable Lck molecules
(Figure 3A, lanes 8 and 11) that had probably been co-Kong et al., 1996). Therefore, we used TCR 1 CD4 co-
crosslinking to determine whether phosphorylation of precipitated by the crosslinking anti-CD4 monoclonal
antibody (MAb) (Veillette et al., 1988), we could not un-ZAP-70 in ST thymocytes actually induced ZAP-70 ki-
nase activity. To do so, anti-ZAP-70 immunoprecipitates equivocally attribute the in vitro PTK activity observed
in this experiment to ZAP-70.from unstimulated and stimulated thymocytes were
halved and assayed in parallel by both immune complex To evaluate ZAP-70 kinase activity in the absence of
Mutation in Murine ZAP-70
667
other kinases, we examined anti-ZAP-70 immunopre-
cipitates from CD41CD81 thymocytes that had been
stimulated with pervanadate, a membrane-permeable
phosphatase inhibitor that results in potent activation
of intracellular PTKs (O'Shea et al., 1992; Secrist et al.,
1993). Pervanadate stimulation, like TCR 1 CD4 co-
crosslinking, induced tyrosine phosphorylation of the
Figure 4. ZAP-70 Molecules from ST Mice Bear a Point Mutation inZAP-70 molecules immunoprecipitated from both ST
the Kinase Domainand WT thymocytes (Figure 3A, lanes 3 and 6), but most
The amino acid sequence corresponding to residues 460±467 ofimportantly, the phosphorylated ZAP-70 molecules from
WT and ST ZAP-70 is shown. The entire ST ZAP-70 nucleotide
ST thymocytes were dramatically devoid of kinase activ- sequence has been submitted to GenBank (accession number
ity (Figure 3A, lanes 9 and 12). Thus, the basis of defec- U77667). A total of eight nucleotide differences in the ST ZAP-70
tive TCR signaling in ST thymocytes appears to be an sequence were detected when compared to the ZAP-70 cDNA se-
quence from normal mice (GenBank accession number UO4379).inability of ZAP-70 phosphorylation to actually induce
Of these, only one, a C-to-T change at position 1498 of the STZAP-70 kinase activity.
ZAP-70 sequence, resulted in an amino acid conversion, an R464CThe absence of ZAP-70 kinase activity in ST thymo-
mutation in the kinase domain. The seven silent nucleotide differ-
cytes might be the result of a mutation in either the ZAP- ences in the ZAP-70 sequence of ST mice relative to the WT se-
70 structural gene itself or in a gene encoding a protein quence may reflect allelic variations.
that regulates ZAP-70 kinase activity. To distinguish be-
tween these two possibilities, we mated ST mice with
with WT B6 mice, reasoning that thymocytes from theZAP-702/2 mice whose ZAP-70 genes were disrupted
resultant B6 3 ZAP2/2 progeny would express reducedby gene targeting (Negishi et al., 1995). As can be seen
levels of fully functional ZAP-70 protein (Figure 5A). In-in Figure 3B, thymocytes from parental ZAP-702/2 and
deed, CD41CD81 thymocytes from B6 3 ZAP2/2 F1 miceST mice were identically arrested at the CD41CD81
expressed ZAP-70 protein at a level reduced to withinstage of differentiation. If the ZAP-70 structural gene in
2-fold of that expressed by ST mice (Figure 5A). Further-ST mice encodes a normal ZAP-70 protein product, then
more, tyrosine phosphorylation of ZAP-70 moleculesST 3 ZAP-702/2 matings should complement the ST
associated with TCR complexes on stimulated CD41defect and restore thymocyte development in the resul-
CD81 thymocytes was virtually identical in B6 3 ZAP2/2tant offspring. Alternatively, if the ZAP-70 structural
and ST mice (Figure 5B). Yet, despite these similaritiesgene in ST mice encodes a defective ZAP-70 protein
in ZAP-70 expression and phosphorylation, thymocyteproduct, then ST 3 ZAP-702/2 matings will fail to com-
development was completely normal in the B6 3 ZAP2/2plement and result in defective offspring. In fact, ST 3
mice (Figure 5C). Taken together, these data demon-ZAP-702/2 matings did not complement, since thymo-
strate that the arrest in thymocyte development in STcytes from F1 offspring were also arrested at the
mice does not result from reduced levels of ZAP-70CD41CD81 stage of differentiation (Figure 3B).
protein but rather from abrogation of ZAP-70 kinaseSince ZAP-70 molecules from ST mice were ex-
activity.pressed at significant levels and migrated normally on
SDS polyacrylamide gel electrophoresis (PAGE) (Figure
Discussion3C), the defect in ZAP-70 was likely to be a very limited
structural mutation. To identify this mutation, we per-
The present study demonstrates that an R-to-C muta-formed reverse transcriptase polymerase chain reaction
tion in the conserved DLAARN motif abrogates ZAP-70(PCR) on RNA derived from ST thymocytes to amplify
kinase activity, resulting in defective TCR signaling andZAP-70 mRNA specifically. cDNAs were generated from
complete arrest of thymocyte development at theindependently derived RNA samples isolated from either
CD41CD81 stage of differentiation. In fact, whileunfractionated thymocytes or from CD41CD81 thymo-
DLAARN is conserved among all PTKs, this is the firstcytes and were subjected to sequence determination.
demonstration that a mutation of the R residue affectsThe ST ZAP-70 sequence contained a total of eight nu-
kinase activity in any PTK molecule.cleotide differences (relative to WT ZAP-70), of which
Mutations of ZAP-70 have not previously been de-seven were silent and possibly reflect allelic variation.
scribed in mice but have been found in humans with aOnly one, a C-to-T mutation at nucleotide 1498, altered
novel form of severe combined immunodeficiency dis-theamino acid sequence. R at position464 was changed
ease (SCID) (Arpaia et al., 1994; Chan et al., 1994b;to C, disrupting the conserved DLAARN motif within the
Elder et al., 1994). The immunodeficiency in these SCIDkinase domain of ST ZAP-70 molecules (Figure 4) (Hanks
patients is characterized by the absence of peripheraland Quinn, 1991). Thus, the defect that attenuated ZAP-
CD81 T cells and the presence of nonfunctional CD4170 kinase activity and arrested thymocyte development
T cells. Interestingly, thymocytes in these patients arein ST mice is a point mutation within the kinase domain
able to mobilize intracellular calcium in response to TCRof ZAP-70.
stimulation (Qian et al., 1996). In contrast, ST mice areBecause mutation of the DLAARN motif of ZAP-70 in
virtually devoid of peripheral T cells, and TCR signalingST thymocytes resulted both in reduced steady-state
in ST thymocytes has been completely abrogated. Thislevels of ZAP-70 protein and in attenuation of ZAP-70
difference in signaling ability may explain why humanskinase activity, it was unclear which was responsible
with defects in ZAP-70 produce mature T cells, whereasfor arresting thymocyte development. To distinguish be-
tween these possibilities, we mated ZAP-702/2 mice ST mice do not. All of the mutations of ZAP-70 that have
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Figure 5. Comparative Analysis of ZAP-70
Expression and Function in ST versus B6 3
ZAP2/2 F1 Thymocytes
(A) ZAP-70 expression levels in ST
CD41CD81 thymocytes are within 2-fold of
that expressed by CD41CD81 thymocytes
from B6 3 ZAP2/2 mice. ZAP-70 molecules
were immunoprecipitated from detergent ex-
tracts of CD41CD81 thymocytes isolated
from the indicated strains of mice. Thymo-
cytes from age- and sex-matched animals
were compared, and ZAP-70 protein content
of the immunoprecipitations was analyzed by
immunoblotting. MED, medium.
(B) Stimulation of ST thymocytes induces ty-
rosine phosphorylation of TCR-associated
ZAP-70 molecules that is equivalent to that
seen in thymocytes from B6 3 ZAP2/2 mice.
CD41CD81 thymocytes from ST, ZAP2/2, and
B6 3 ZAP2/2 mice were stimulated with per-
vanadate and extracted with detergent and
the lysates immunoprecipitated with anti-
TCRz antibody. The resultant immunoprecipi-
tations were analyzed by anti-phosphotyro-
sine immunoblotting.
(C) Thymocyte development is not disrupted
in B6 3 ZAP2/2 animals. Thymi from the indi-
cated mice were assessed for CD4 versus
CD8. Notably, mature CD41 and CD81 thymo-
cytes were present in B6 3 ZAP2/2 but not
ST mice.
been reported to cause SCID in humans cluster in the whereby ZAP-70 might mediate TCR signaling in thymo-
cyte development: ZAP-70 might phosphorylate down-kinase domain between amino acids 504 and 542 (Figure
6), and all result in instability of ZAP-70 protein, virtually stream cytosolic signaling molecules that are part of
the TCR signaling cascade (Wardenburg et al., 1996);eliminating its expression in these patients. Conse-
quently, the T cell defects in these patients may simply alternatively, ZAP-70, when phosphorylated by p56lck,
might serve as a molecular scaffold or linker proteinreflect the loss of ZAP-70 protein. In contrast, the R464C
ZAP-70 mutation in ST mice does not eliminate ZAP-70 that attracts cytosolic signaling molecules to the TCR
complex. The requirement for ZAP-70 enzymatic activityexpression; rather, the ZAP-70 molecules present in ST
thymocytes cannot be activated. In fact, abrogation of demonstrated in this report is consistent with ZAP-70
phosphorylation of downstream targets and excludesZAP-70 kinase activity by the novel, spontaneously aris-
ing R464C ST mutation has a potential structural basis, the possibility that exogenous phosphorylation of ZAP-
70 is sufficient to form a molecular scaffold for TCRprovided by analogy with the crystal structure of the
human insulin receptor PTK domain. This crystallo- signaling in thymocyte development. Rather, if ZAP-70
does have a significant role as a molecular scaffold ingraphic analysis predicts that the R residue of the
DLAARN motif, which comprises the catalytic loop of the TCR signaling in vivo, autophosphorylation of molecular
docking sites by its own intrinsic kinase activity is re-kinase domain, might influence the phosphotransferase
active site of PTKs both by neutralizing charges at the quired (Neumeister et al., 1995).
Finally, it should be noted that we originally detectedphosphotransfer site and by hydrogen boding with the
catalytic base (Hubbard et al., 1994). the ST mutation in a colony of mice that had been de-
rived from embryonic stem cells whose CD28 gene hadImportantly, since ST mice express a catalytically in-
active form of ZAP-70, the present study represents the been disrupted by gene targeting. Since the ST mutation
is entirely independent of CD28 expression, its occur-first demonstration that ZAP-70 PTK activity is neces-
sary for thebiological role of ZAP-70 invivo in thymocyte rence in a CD28 knockout mouse colony was simply
fortuitous. Since the ST mutation is a point mutation, itdevelopment. ZAP-70 kinase activity is necessary for
early TCR signaling events such as PLCg phosphoryla- cannot have been a direct consequence of the gene
targeting procedure to which the original embryoniction and calcium mobilization as well as for very distal
events such as thecell fate decisions involved in positive stem cells were subjected, a conclusion that is also
consistent with our failure to detect the gene targetingselection. These findings support and significantly ex-
tend the recent demonstration that ZAP-70 kinase activ- vector in genomic DNA from ST mice. However, origina-
tion of the ST mutation in the CD281/2 mouse colonyity was necessary for TCR signaling in an in vitro cell
line (Qian et al., 1996). There are two mechanisms indicates that the mutation occurred either in the
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Figure 6. ZAP-70 Mutations Producing Im-
munodeficiency in Mice and Humans
The position and type of known mutations
within ZAP-70 kinase domain that produce
immunodeficiency are indicated: (1) deletion
hSCID, a 13 bp deletion spanning nucleotides
1719±1731, observed in human immunodefi-
ciency; (2) R hSCID, a point mutation at nucle-
otide 1763 that changes serine to arginine
at position 518 in human immunodeficiency;
and (3) insertion hSCID, a 9 bp insertion at
nucleotide 1832 that introducesthe tripeptide
leucine±glutamic acid±glutamine (LEQ) at po-
sition 542 (Arpaia et al., 1994; Chan et al.,
1994b; Elder et al., 1994). 1 indicates the in-
creased kinase activity upon phosphorylation
of Y493; 2 indicates the observed inhibitory
effect of Y492 on kinase activity (Watts et al.,
1994; Chan et al., 1995; Wange et al., 1995).
cytometry as described (Nakayama et al., 1989). Thymic explantsCD281/2 mouse colony itself or in the embryonic stem
from which CD41CD81 thymocytes were to be isolated were strictlycells from which these mice were originally derived. In
kept at 48C during isolation and purification. CD41CD81 thymocyteseither case, its occurrence serves as a demonstration
were isolated by panning on anti-CD8 coated plates (Nakayama et
that dramatic phenotypes can arise as a result of sponta- al., 1989) and were consistently greater than 96% CD41CD81.
neous mutations in embryonic stem cell±derived mice
that may be unrelated to the identity of the originally Surface Biotin Labeling and Two-Dimensional Electrophoresis
CD41CD81 thymocytes from DO11.10 TCR transgenic WT and STtargeted gene of interest.
mice were surface-labeled with biotin, extracted with lysis buffer
containing 1% digitonin (Wako, Kyoto, Japan), and immunoprecipi-Experimental Procedures
tated with anti-TCRb (H57±597) MAb adsorbed to protein A±Sepha-
rose beads as described (Wiest et al., 1995). The resultant immuneMice
complexes were resolved on two-dimensional SDS-PAGE gels andYoung adult C57BL/6 (B6) mice were obtained from the National
visualized using horseradish peroxidase±conjugated streptavidinCancer Institute (Frederick, MD). The following transgenic and gene-
and chemiluminescence as described (Wiest et al., 1995).targeted mice were used in this study: (1) DO11.10 TCR transgenic
mice obtained from Dr. D. Y. Loh (Nippon Roche Research Center)
Calcium Mobilization(Murphy et al., 1990); (2) CD282/2 mice obtained from Dr. Tak Mak
CD41CD81 thymocytes were strictly maintained at 48C until they(Toronto University) (Shahinian et al., 1993); and (3) ZAP-702/2 mice
were loaded at 107/ml in 2% fetal calf serum/RPMI with 1 mg/mlgenerated as described (Negishi et al., 1995).
indo-1 (Molecular Probes, Eugene, OR) for 30 min at 318C. The cells
were then stained for 20 min at 48C with 1 mg each of the indicatedIntercross Analysis
biotinylated MAbs: anti-TCRb (H57±597); anti-CD4 (GK1.5); and anti-Mice with the ST phenotype arose during intercrossing CD282/2
CD8 (2.43). After washing with 0.5% bovine serum albumin/Hank'swith B6 mice. The possibility that the ST mutation was a defect in
balanced salt solution at 48C, the cells were warmed to 378C andTCRa or b subunits was assessed by intercrossing ST mice with
immediately loaded into an Epics Elite cytometer (Coulter, Hialeah,mice expressing the transgenic TCRab subunits of the DO11.10
FL). Calcium mobilization was analyzed following avidin crosslinkingTCR. F1 progeny from this mating were intercrossed. Thirty F2 ani-
(4 mg/ml) by monitoring the fluorescence emission ratio at 395mals from these matings were examined. Of the 30, approximately
nM:525 nM after excitation of indo-1 at 325 nM with a helium-cad-75% bore the DO11.10 transgenic TCR as indicated by PCR analysis
mium laser. Data were analyzed using the Multitime program (Phoe-on tail DNA using the following primers: Va13.1 59-CAGGAGGGATC
nix Flow Systems, San Diego, CA).CAGTGCCAGC-39 and Ja 59-TGGCTCTACAGTGAGTTT GGT 39.
Of the transgenic F2 offspring, 25% had the ST phenotype, as evi-
denced by the absence of peripheral blood T cells. This is the ex- Stimulation
Freshly isolated CD41CD81 thymocytes (50±80 3 106 per sample)pected frequency for an autosomal recessive trait among F2 prog-
eny in such a breeding regimen. were pelleted and resuspended at107/ml in ice cold RPMI containing
1 mM Na3VO4 and 10 mg/ml each of the biotinylated MAbs anti-CD4
and anti-TCRb. Cells werestained for 10 min at 48C and thenpelletedAntibodies
The following fluor-conjugated MAbs purchased from Pharmingen and resuspended in 1 ml of 20 mg/ml streptavidin (Southern Biotech-
nology Associates, Inc., Birmingham, AL) that was prewarmed to(SanDiego, CA) were used in flow cytometry: fluoresceinated anti-
TCRb (H57±597) (Kubo et al., 1989); fluoresceinated anti-CD4 378C. After a 5 min incubation at 378C, the cells were immediately
lysed in buffer containing 1% Triton X-100 detergent and phospha-(RM4.5); phycoerythrin-anti-CD8 (53±6.7) (Ledbetter et al., 1980);
fluoresceinated anti-B220 (RA3±6B2) (Asensi et al., 1989); phycoery- tase inhibitors (1 mM Na3VO4 and 2 mM EDTA) and immunoprecipi-
tated with the indicated antibody, either anti-PLCg or anti-ZAP-70.thrin-anti-Thy1.2 (30-H12) (Ledbetter et al., 1980); and phycoery-
thrin±anti-CD5 (53±7.3) (Ledbetter et al., 1980). The following anti- CD41CD81 thymocytes to be stimulated with pervanadate were
resuspended at 107/ml in a 378C solution containing 0.3 mM H202bodies were used in signaling experiments: anti-CD4 (GK1.5)
(Dialynas et al., 1983); anti-CD8 (2.43) (Dialynas et al., 1983); anti- and 0.1 mM Na3VO4 and incubated for 10 min at 378C as described
(Wiest et al., 1996). Immune complexes were then analyzed eitherTCRb (H57±597); anti-phosphotyrosine (4G10) (UBI, Lake Placid,
NY); rabbit anti-ZAP-70 (Burkhardt et al., 1994); rabbit anti-Lck (se- by anti-phosphotyrosine immunoblotting or by immune complex
kinase assay as indicated. Immune complexes to be analyzed byrum 688) (Samelson et al., 1990); and anti-PLCg (UBI).
anti-phosphotyrosine immunoblots were eluted in SDS-sample
buffer, resolved by SDS-PAGE, and transferred to Immobilon PVDFCell Preparation and Flow Cytometry
Single cell suspensions were produced from freshly explanted thy- membranes (Millipore, Bedford, MA) as described (Wiest et al.,
1993). Tyrosine phosphorylated proteins were identified by probingmus, spleen, and lymph node tissue and then analyzed by flow
Immunity
670
blots with anti-phosphotyrosine MAb (1 mg/ml) and developing them Chan, A.C., Iwashima, M., Turck, C.W., and Weiss, A. (1992). ZAP-
70: a 70 kD protein-tyrosine kinase that associates with the TCRwith horseradish peroxidase±conjugated protein-A (Kirkegaard
zeta chain. Cell 71, 649±662.Perry Laboratories, Gaithersburg, MD) diluted 1:2500 in phosphate-
buffered saline containing 0.4% Tween-20 followed by chemilumi- Chan, A.C., Desai, D.M., and Weiss, A. (1994a). The role of protein-
nescence biotin (SuperSignal, Pierce Chemical, Rockford, IL). PLCg tyrosine kinases and protein-tyrosine phosphatases in T cell antigen
and Lck were identified by probing blots with anti-PLCg and anti- receptor signal transduction. Annu. Rev. Immunol. 12, 555±592.
Lck as described (Wiest et al., 1996). Immune complexes to be Chan, A.C., Kadlecek, T.A., Elder, M.E., Filipovich, A.H., Kuo, W.L.,
analyzed by kinase assay were incubated at ambient temperature Iwashima, M., Parslow, T.G., and Weiss, A. (1994b). ZAP-70 defi-
for 3 min in kinase buffer containing 15 mCi/sample of g32P-ATP (ICN ciency in an autosomal recessive form of severe combined immuno-
Biomedicals), after which the immune complexes were resolved by deficiency. Science 264, 1599±1601.
SDS-PAGE and visualized by autoradiography (Wiest et al., 1993). Chan, A.C., Dalton, M., Johnson, R., Kong, G., Wang, T., Thoma, R.,
Radiolabeled proteins in the immune complex kinase assay reflect and Kurasaki, T. (1995). Activation of ZAP-70 kinase activity by
transfer of 32P by an activated PTK molecule present in the anti- phosphorylation of tyrosine 493 is required for lymphocyte antigen
ZAP-70 immunoprecipitation. receptor function. EMBO J. 14, 2499±2508.
Dialynas, D.P., Wilde, D.B., Marrack, P., Peirres, A., Wall, K.A., Hav-
Sequence Analysis of ZAP-70 from ST Mice ran, W., Otten, G., Loken, M.R., Pierres, M., Kappler, J., et al. (1983).
Total RNA was derived from ST thymocytes using the guanidine Characterization of the murine antigenic determinant, designated
isothiocyanate method as described (Sambrook et al., 1989). ST L3T4a, recognized by monoclonal antibody GK1.5: expression of
ZAP-70 cDNA was synthesized using rTth DNA polymerase, XL (Per- L3T4a by functional T cell clones appears to correlate primarily with
kin-Elmer, Norwalk, CT), and antisense primers 59-CTCAGCCACAT class II MHC antigen-reactivity. Immunol. Rev. 74, 29±56.
GCAGCCTCGGCCACCTGTTC-39 or 59-CCATGGCCACCTGGTGCA Elder, M.E., Lin, D., Clever, J., Chan, A.C., Hope, T.J., Weiss, A.,
GCAGTTCAGC-39, from which the amino- and carboxy-terminal re- and Parslow, T.G. (1994). Human severe combined immunodefi-
gions of the ST ZAP-70 cDNA were PCR-amplified using sense ciency due to a defect in ZAP-70, a T cell tyrosine kinase. Science
primers 59-ATGCCCGATCCCGCGGCGCACCTGCCATTCTT-39 and 264, 1596±1599.
59-GCTGAACTGCTGCACCAGGTGGCCATGG-39, respectively. Am- Gelfand, E.W., Weinberg, K., Mazer, B.D., Kadlecek, T.A., and Weiss,
plified fragments were incubated with Taq polymerase for an addi- A. (1995). Absence of ZAP-70 prevents signaling through the antigen
tional 10 min at 728C and subcloned in the pCRII cloning vector receptor on peripheral blood T cells but not on thymocytes. J. Exp.
(Invitrogen, San Diego, CA). Plasmid minipreps containing the mu- Med. 182, 1057±1066.
tant ZAP-70 cDNA were sequenced using the ABI PRISM Dye Termi-
Hanks, S.K., and Quinn, A.M. (1991). Protein kinase catalytic domainnator Cycle Sequencing Reaction Kit (Perkin Elmer), a PTC-200 Pel-
sequence database: identification of conserved features of primarytier Thermal Cycler (MJ Research, Watertown, MA), and an ABI
structure and classification of family members. Meth. Enzymol. 200,373 DNA Sequencer (Perkin Elmer). The resultant cDNAs were then
38±62.
subjected to DNAsequence determination; overlapping cDNAs were
Hashimoto, K., Sohn, S.J., Levin, S.D., Tada, T., Perlmutter, R.M.,sequenced in both directions. As a control, WT ZAP-70 cDNA (pro-
and Nakayama, T. (1996). Requirement for p56(lck) tyrosine kinasevided by Dr. Andrey Shaw, GenBank accession number UO4379)
activation in T cell receptor-mediated thymic selection. J. Exp. Med.was sequenced in parallel.
184, 931±943.
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